1. Home
  2. JCE vs INGN Comparison

JCE vs INGN Comparison

Compare JCE & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCE
  • INGN
  • Stock Information
  • Founded
  • JCE 2007
  • INGN 2001
  • Country
  • JCE United States
  • INGN United States
  • Employees
  • JCE N/A
  • INGN N/A
  • Industry
  • JCE Trusts Except Educational Religious and Charitable
  • INGN Industrial Specialties
  • Sector
  • JCE Finance
  • INGN Health Care
  • Exchange
  • JCE Nasdaq
  • INGN Nasdaq
  • Market Cap
  • JCE 262.6M
  • INGN 219.3M
  • IPO Year
  • JCE N/A
  • INGN 2014
  • Fundamental
  • Price
  • JCE $15.53
  • INGN $8.32
  • Analyst Decision
  • JCE
  • INGN Strong Buy
  • Analyst Count
  • JCE 0
  • INGN 3
  • Target Price
  • JCE N/A
  • INGN $11.00
  • AVG Volume (30 Days)
  • JCE 49.7K
  • INGN 184.2K
  • Earning Date
  • JCE 01-01-0001
  • INGN 11-06-2025
  • Dividend Yield
  • JCE 9.26%
  • INGN N/A
  • EPS Growth
  • JCE N/A
  • INGN N/A
  • EPS
  • JCE N/A
  • INGN N/A
  • Revenue
  • JCE N/A
  • INGN $343,472,000.00
  • Revenue This Year
  • JCE N/A
  • INGN $7.68
  • Revenue Next Year
  • JCE N/A
  • INGN $6.47
  • P/E Ratio
  • JCE N/A
  • INGN N/A
  • Revenue Growth
  • JCE N/A
  • INGN 5.15
  • 52 Week Low
  • JCE $11.64
  • INGN $5.70
  • 52 Week High
  • JCE $14.28
  • INGN $12.91
  • Technical
  • Relative Strength Index (RSI)
  • JCE 44.11
  • INGN 59.86
  • Support Level
  • JCE $15.52
  • INGN $8.21
  • Resistance Level
  • JCE $15.81
  • INGN $8.70
  • Average True Range (ATR)
  • JCE 0.17
  • INGN 0.33
  • MACD
  • JCE -0.03
  • INGN -0.01
  • Stochastic Oscillator
  • JCE 2.08
  • INGN 61.22

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Share on Social Networks: